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Abstract
 
CD27, like CD28, acts in concert with the T cell receptor to support T cell expansion. Using
CD27
 
 
 
/
 
  
 
mice, we have shown earlier that CD27 determines the magnitude of primary and
memory T cell responses to influenza virus. Here, we have examined the relative contributions
of CD27 and CD28 to generation of the virus-specific effector T cell pool and its establishment
at the site of infection (the lung), using CD27
 
 
 
/
 
 
 
, CD28
 
 
 
/
 
 
 
, and CD27/CD28
 
 
 
/
 
  
 
mice. We
find that primary and memory CD8
 
  
 
T cell responses to influenza virus are dependent on the
collective contribution of both receptors. In the primary response, CD27 and CD28 impact to
a similar extent on expansion of virus-specific T cells in draining lymph nodes. CD27 is the
principle determinant for accumulation of virus-specific T cells in the lung because it can sustain
this response in CD28
 
 
 
/
 
  
 
mice. Unlike CD28, CD27 does not affect cell cycle activity, but
promotes survival of activated T cells throughout successive rounds of division at the site of
priming and may do so at the site of infection as well. CD27 was found to rescue CD28
 
 
 
/
 
  
 
T
cells from death at the onset of division, explaining its capacity to support a T cell response in
absence of CD28.
Key words: costimulation • apoptosis • inﬂuenza virus • MHC tetramer • CFSE
 
Introduction
 
An effective immune response is based on a dramatic increase
in numbers of antigen-specific T cells. It is qualitatively
tuned by their differentiation into cells with the appropriate
effector functions. Naive T cells generally cannot expand
efficiently upon TCR stimulation alone. A second signal is
required, which is provided by membrane receptors on the
T cell and their ligands on the antigen-presenting cell.
CD28 provides such a costimulatory signal. It promotes
assembly of the T cell signaling complex and primarily
amplifies signals delivered via the TCR (1). This decreases
the threshold for T cell recruitment into the dividing pool,
resulting in responsiveness at lower doses of antigen (2).
CD28 increases IL-2 production and thus enhances cell
cycle activity. CD28 also promotes survival of activated T
cells through a pathway, which up-regulates the apoptosis
inhibitory Bcl-2 family member Bcl-x
 
L 
 
(3, 4). These obser-
vations support the concept that numerical expansion of
activated T cells is not only dependent on cell division, but
also on cell survival.
Several members of the TNF receptor family, including
CD27 and its close relatives 4-1BB (CD137) and OX40
(CD134), have recently moved to center stage as costimu-
latory receptors (5). These molecules link to members of the
TNF receptor–associated factor (TRAF) family of signaling
adaptors via small, ill-conserved motifs in their cytoplasmic
tails. Biochemical and genetic studies support a role for
TRAFs and TRAF-linked receptors in counteracting apop-
totic signals, but there is also evidence for effects on cell
proliferation, differentiation, and migration (6, 7).
Expression of these receptors and their transmembrane,
TNF-related ligands is selective in time and place and
tightly controlled by antigenic stimulation. In man and
mouse, CD27 is restricted to lymphoid cells. It is present
on the great majority of naive CD4
 
  
 
and CD8
 
  
 
T cells, and
transiently up-regulated upon priming (8, 9). CD70, the
ligand of CD27, is exclusively expressed on activated lym-
phocytes and mature DCs. On T cells, CD70 is induced by
the TCR and modulated by cytokines (10–12). On DCs, it
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 APC, allophycocyanin; CFSE, carboxy-
fluorescein diacetate succinimidyl ester; DLN, draining lymph node; NP,
nucleoprotein; PI, propidium iodide; TRAF, TNF receptor–associated
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is induced by CD40, or by “danger” signals, such as LPS
(12, 13). Therefore, CD27–CD70 interaction can come
into play during T–DC and T–T cell communication and
is expected to contribute to the T cell response both at the
site of priming and at the effector site.
In vitro, CD27 can give a costimulatory signal to puri-
fied naive T cells that promotes T cell expansion (14, 15).
In CD27
 
 
 
/
 
  
 
mice, as generated in our laboratory, T cell
development and homeostasis are normal. However, upon
intranasal infection with influenza virus, CD27
 
 
 
/
 
  
 
mice
displayed deficits in generation of antigen-specific T cells in
lymphoid organs and in establishment of CD4
 
  
 
and CD8
 
 
 
T cell pools at the effector site, i.e., the lung. CD27 dele-
tion impacted on the primary as well as the memory re-
sponse (16). CD70 transgenic mice essentially display the
reverse phenotype. Both CD4
 
  
 
and CD8
 
  
 
T cells with an
effector phenotype accumulate in these mice (17, 18).
Using intranasal infection with influenza virus as a model
system, we show that CD27 is as important as CD28 for
generation of a virus-specific T cell pool in lung draining
lymph nodes (DLNs) and the main determinant for accu-
mulation of these cells at the site of infection (the lung).
CD27 makes this contribution not by affecting cell cycle
activity, but by stimulating the survival of activated T cells,
also in the absence of CD28 signals.
 
Materials and Methods
 
Mice.
 
All mice were bred under pathogen-free conditions and
were used for experiments at 6–10 wk of age. Animal experiments
were performed according to institutional and national guidelines.
CD27
 
 
 
/
 
  
 
mice (16) and CD28
 
 
 
/
 
  
 
mice (19) were backcrossed for
8 and 10 generations to a C57BL/6 background, respectively.
Offspring was genotyped by PCR on tail DNA as previously de-
scribed (16, 19). F5 TCR transgenic mice (20) and H-Y TCR
transgenic mice (21) were phenotyped by staining of peripheral
blood samples with antibody to V
 
 
 
11 or V
 
 
 
8, respectively.
 
Flow Cytometry.
 
Lung, spleen, and lymph nodes were forced
through a nylon mesh in the presence of IMDM with 8% FCS to
obtain single cell suspensions. Erythrocytes were lysed by incuba-
tion of the harvested cell population in 0.14 M NH
 
4
 
Cl, 0.017 M
Tris-HCl, pH 7.2, for 2 min on ice. Cells were preincubated
with Fc-Block (mAb to CD16/CD32, 2.4G2; BD Biosciences)
and washed in staining buffer (PBS, 0.5% BSA, 0.01% sodium
azide). Next, cells were incubated with specific antibodies di-
rectly conjugated to FITC, PE, or allophycocyanin (APC). APC-
labeled tetramers of the murine MHC class I H2-D
 
b 
 
heavy chain,
 
 
 
2 microglobulin, and the influenza virus nucleoprotein
(NP)
 
366–374 
 
peptide ASNENMDAM were prepared as previously
described (22) and used for immunofluorescence in combination
with anti-CD8 mAb. After incubation with respective antibodies
and tetramers, cells were washed and analyzed using a FACSCali-
bur™ and CELLQuest™ software (Becton Dickinson). mAbs
used for immunofluorescence were anti-CD3
 
 
 
, 500A2; anti-
CD8b.2, 53-5.8; anti-CD27, LG.3A10 (15); anti-CD28, 37.51;
anti-CD45R/B220, RA3-6B2; anti-CD45.1, A20; anti-V
 
 
 
8,
F23.1; and anti-V
 
 
 
11, RR3-15. They were purchased from BD
Biosciences or donated by investigators.
 
Preparation of Purified T Cells.
 
Cell suspensions were prepared
as described above, passed over nylon wool (Polysciences) and in-
cubated on ice for 30 min with mAb M5/114.15.2 to MHC class
II (BD Biosciences). This was followed by 30 min of incubation
on ice with 100 
 
 
 
l goat anti–mouse Ig-coated magnetic beads and
20 
 
 
 
l sheep anti–rat Ig-coated magnetic beads (Advanced Mag-
netics Inc.) per 10
 
7 
 
cells. Beads were removed by magnetic sorting.
Purity of the resulting cell population was checked with anti-
CD3
 
  
 
and anti-B220 mAbs. Only preparations that contained
 
 
 
98% T cells were used for stimulation or adoptive transfer.
 
In Vitro T Cell Stimulation.
 
For cell cycle analysis, T cells pu-
rified from pooled spleen and lymph node cells were labeled with
carboxy-fluorescein diacetate succinimidyl ester (CFSE; Molecu-
lar Probes Inc.) before stimulation. Cells were incubated at a con-
centration of 5 
 
  
 
10
 
7 
 
cells/ml in PBS, containing 0.1% BSA and
5 
 
 
 
M CFSE, for 10 min at 37
 
 
 
C. Labeling was quenched with 10
ml cold medium with 10% FCS and cells were washed twice with
IMDM with 8% FCS before use. For in vitro T cell stimulation
with antibodies, purified T cells were plated at 10
 
5 
 
per well in
IMDM with 8% FCS in 96-well plates, which were coated with
mAb 145-2C11 to CD3
 
  
 
at 2.5 
 
 
 
g/ml, in the presence or ab-
sence of 10 
 
 
 
g/ml coated mAb 37.51 to CD28 or 0.1 
 
 
 
g/ml sol-
uble mAb LG.3A10 to CD27. Mouse anti–rat Ig
 
  
 
chain mAb
RG7/7.6, which also reacts with hamster Ig
 
 
 
, was added at 25
 
 
 
g/ml to cross-link anti-CD27 mAb. After culture, live cells
were counted on an automated cell counter (CASY
 
®
 
1, model
TT; Schärfe-System). Before analysis, cells were incubated with
TO-PRO-3 (Molecular Probes) at 1 
 
 
 
M in FACS
 
® 
 
buffer for 10
min. Samples were analyzed for CFSE and TO-PRO-3 fluores-
cence intensity on a FACSCalibur™.
 
Apoptosis Assays.
 
To determine nuclear fragmentation (sub-
diploid DNA content), cells were lysed in 0.1% sodium citrate,
0.1% Triton X-100, and 50 
 
 
 
g/ml propidium iodide (PI). Fluo-
rescence intensity of nuclei and nuclear fragments was measured
by flow cytometry as previously described (23). Exposure at the
outer plasma membrane leaflet of phosphatidyl serine was deter-
mined using FITC-labeled annexin V (APOPTEST™; Nexins
Research BV) as previously described (24). 5 
 
 
 
g/ml PI was added
before analysis and cells with high PI fluorescence intensity were
excluded from analysis.
 
Virus Infection.
 
Influenza virus strain A/NT/60/68 was ob-
tained from the Department of Virology, Erasmus University
Rotterdam, Netherlands. Mice were anesthetized and infected
intranasally with 50 
 
 
 
l Hank’s balanced salt solution containing
25 or 100 hemagglutinin units of the same virus for primary and
memory responses, respectively.
 
Adoptive Transfers.
 
Purified T cells from lymph nodes of
TCR transgenic F5 CD27
 
 
 
/
 
 
 
, F5 CD28
 
 
 
/
 
 
 
, and F5 wild-type
mice were mixed 1:1 with purified H-Y TCR transgenic nonre-
sponder T cells (5 
 
  
 
10
 
6 
 
of each) and all were labeled with CFSE.
The mix was suspended in 200 
 
 
 
l Hank’s balanced salt solution
and injected intravenously into female C57BL/6 recipients ex-
pressing the CD45.1 allotype. Mice were infected with influenza
virus 2 d later. At indicated time points, DLNs, lung, and spleen
were isolated and prepared for analysis. For the experiment de-
picted in Fig. 4, purified naive F5 T cells were injected at 15 
 
 
 
10
 
6 
 
into recipient mice, which were infected with influenza virus
2 d later. At day 4 after infection, T cells were purified from
DLNs of recipients, mixed at a 1:1 ratio with purified H-Y TCR
transgenic T cells, and labeled with CFSE. A mix of 10
 
6 
 
T cells of
each was injected intravenously into recipient mice, which had
been infected with influenza virus on the same day as the donor
mice. Cells recovered from DLNs and lung were stained with
PE-conjugated anti-V
 
 
 
8 and anti-CD45.1 mAbs and APC-con-
jugated H2-D
 
b 
 
NP
 
366–374 
 
tetramers. PI was added just before anal-T
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ysis and PI
 
  
 
cells were excluded from analysis. Within the win-
dow detecting green fluorescence (CFSE), 1,000 nonresponder
events (H-Y TCR transgenic T cells, V
 
 
 
8
 
 
 
) were collected from
DLNs or spleen and 500 from the lung. Analysis of cell division
was performed on the simultaneously collected F5 TCR trans-
genic responder T cells, allowing for quantitative comparison of
the CFSE histograms.
 
Results
 
Virus-specific T Cell Responses in Mice Lacking CD27,
CD28, or Both.
 
To determine the relative contributions
of CD27 and CD28 to the T cell response, intranasal infec-
tion of C57BL/6 mice with influenza virus was used. In
this model system, influenza virus causes a localized infec-
tion in the respiratory tract and is characterized by an influx
of both CD4
 
  
 
and CD8
 
  
 
effector T cells into the lung (16).
The CD8
 
  
 
T cell response can be monitored with H-2D
 
b
 
MHC class I tetramers, loaded with the immunodominant
peptide NP
 
366–374 
 
(22).
Wild-type, CD27
 
 
 
/
 
 
 
, CD28
 
 
 
/
 
 
 
, and CD27/CD28
 
 
 
/
 
 
 
double deficient mice were infected and analyzed 6, 8, 10,
or 14 d later for the presence of virus-specific CD8
 
  
 
T
cells. In the lung, accumulation of wild-type virus-specific
T cells became detectable at day 6 and peaked at days 8–10
after infection (Fig. 1 A). In CD28
 
 
 
/
 
  
 
mice, the T cell re-
sponse at this site was partially intact, whereas it was almost
completely abrogated upon additional CD27 deletion. Ap-
parently, CD27 can support the virus-specific CD8
 
  
 
T cell
response in the lung in absence of CD28. Accumulation of
virus-specific CD8
 
  
 
T cells in the lung of CD27
 
 
 
/
 
  
 
mice
was in fact much lower than in CD28
 
 
 
/
 
  
 
mice, indicating
Figure 1. In vivo primary and
memory T cell responses to influenza
virus in the presence or absence of
CD27 and/or CD28. Wild-type,
CD27 / , CD28 / , and CD27 / /
CD28 /  mice were infected intra-
nasally with influenza virus. Cells
were isolated from the lung, DLNs,
and spleen on the indicated days after
infection. They were counted,
stained with anti-CD8 mAb and
NP366–374/H2-Db tetramers, and ana-
lyzed by flow cytometry. Each symbol
represents an individual mouse (four
per group) and dashes represent
mean values. (A) Primary response.
(B) Memory response. The complete
experiment was performed two
times with reproducible results.T
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that CD27 is a major determinant for the CD8
 
  
 
T cell re-
sponse at the site of infection. The response at the site of
priming, the mediastinal lung DLNs, was strongly reduced
in both CD27
 
 
 
/
 
  
 
and CD28
 
 
 
/
 
  
 
mice compared with wild-
type mice, and virtually absent in CD27/CD28
 
 
 
/
 
  
 
mice,
indicating that both receptors make crucial and in part
complimentary contributions to generation of the virus-
specific CD8
 
  
 
T cell pool. Strikingly, in the spleen, CD27
deficiency only had a minor effect, whereas CD28 deletion
strongly reduced the response. Accumulation of virus-spe-
cific CD8
 
  
 
T cells in the spleen appeared fully dependent
on the collective contribution of CD27 and CD28. In the
absence of both molecules, increase in tetramer
 
  
 
T cells
was virtually undetectable.
To study the impact of CD27 and/or CD28 deletion on
the memory T cell response, mice were rechallenged with
the same virus 6 wk after primary infection. As shown in
Fig. 1 B, the wild-type memory response is characterized
by more rapid kinetics and an increased magnitude of vi-
rus-specific T cell accumulation, in particular in DLNs and
lung. In the lung, the response peaks at day 5 rather than at
days 8–10 and peak values of NP-specific CD8
 
  
 
T cells are
about fourfold higher than in the primary response. In mice
lacking CD27, CD28, or both, virus-specific T cell accu-
mulation in the lung remained at levels seen in the primary
response of these mice, indicating a severe reduction in
memory. In DLNs, impact of single CD27 or CD28 dele-
tion was somewhat less severe than in lung. In spleen,
memory responses were reduced by either CD27 or CD28
deletion, indicating a stronger impact of CD27 deletion on
the memory response in the spleen than on the primary re-
sponse at this site.
We conclude that during the primary response, genera-
tion of the CD8
 
  
 
virus-specific T cell pool in DLNs and its
establishment at the site of infection is greatly dependent
on the collective, partially nonredundant contribution of
CD27 and CD28. CD27 is able to sustain effector T cell
accumulation in the lung in the absence of CD28 during
Figure 2. Impact of CD27 or CD28 deletion on division and accumu-
lation of influenza virus-specific T cells in DLNs. CD45.1  recipient mice
were injected with a 1:1 mix of CD45.1  CFSE-labeled F5 and H-Y
TCR transgenic naive T cells and infected with influenza virus 2 d later.
(A) Recovery of CFSE-labeled wild-type or CD27 /  T cells from the
spleen of noninfected recipient mice at day 8 after adoptive transfer, or
from DLNs of recipient mice at day 4 after virus infection. The circles
indicate nonresponding V 8  H-Y T cells, rectangles V 8  F5 T cells,
small arrows indicate divisions in the responding F5 population. Percentages
of H-Y and F5 T cells were calculated relative to recipient cells. (B) DLNs
were harvested at day 2, 3, or 4 after infection. To standardize recovery of
F5 T cells, 1,000 H-Y T cells were collected. Wild-type (solid line),
CD27 / , or CD28 /  (dotted lines) F5 T cell responses are quantitatively
compared by overlay of CFSE histograms. (C) Kinetics of accumulation of
wild-type, CD27 / , and CD28 /  F5 responder T cells in DLNs of
influenza virus-infected mice. The absolute numbers of F5 T cells were
calculated from the total number of cells and the percentage of F5 T cells
(V 8/CD45.1 ). Means and standard deviations were derived from four
mice per time point out of two independent experiments.T
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the primary response. The memory response in the lung is
more dependent on CD28 than the primary response. Al-
though T cell responses in DLNs and lung show similar re-
quirements for CD27 and CD28, the response in the
spleen appears to be regulated differently. In the primary
response, CD28 rather than CD27 is required for accumu-
lation of virus-specific CD8  T cells at this site, whereas
the memory response depends similarly, but not fully, on
both receptors.
CD27 on Virus-specific T Cells Promotes Their Expansion at
the Site of Priming, but Has No Effect on Cell Division. Sub-
sequent experiments were designed to determine by
which mechanisms CD27 and CD28 contributed to gen-
eration of the virus-specific T cell pool in DLNs during
the primary response. We made use of adoptive transfer of
CFSE-labeled T cells to follow successive cycles of cell
division. As responder cells, F5 TCR transgenic T cells
were used, which are specific for the NP366–374–H-2Db
complex (20). To allow for quantitative comparison of the
CFSE profiles, a population of nonresponder TCR trans-
genic T cells was used with specificity for the male anti-
gen H-Y (21). Labeled F5 and H-Y T cells were coin-
jected in a 1:1 ratio into female mice. 2 d later, mice were
challenged with influenza virus. At the indicated time
points after infection, cells were harvested and stained
with anti-V 8 mAb to detect H-Y TCR transgenic T
cells and with antibody to CD45.1 to detect cells of the
recipient mouse. F5 T cells were characterized by CFSE
staining and lack of CD45.1 or V 8 expression. MHC
class I tetramers proved ineffective to identify primed F5
T cells, due to marked down-regulation of their TCR
upon virus recognition (not depicted). Recovery of wild-
type and CD27 /  F5 T cells from the spleen of nonin-
fected mice at day 8 after injection was similar, indicating
that CD27 deficiency did not alter the ability of T cells to
survive in the absence of antigenic stimulation (Fig. 2 A).
CFSE staining of F5 T cells, taken from DLNs at day 4 af-
ter virus infection, marked successive divisions, whereas
H-Y T cells had not divided, corroborating their nonre-
sponsiveness in this system. Recovery of H-Y T cells was
similar when coinjected with either wild-type or CD27 / 
F5 T cells both in noninfected and infected mice, ensur-
ing the validity of using these cells as a standard. Using
this experimental setup, we followed kinetically the re-
sponse of wild-type, CD27 / , and CD28 /  F5 T cells
in DLNs (Fig. 2 B). Although at day 2 after virus infec-
tion, adoptively transferred wild-type F5 T cells had not
yet divided, 24 h later a large proportion of these cells had
already completed up to five divisions. This finding high-
lights the capacity of newly activated T cells to cycle very
rapidly. At day 4 after infection, wild-type F5 T cells had
further progressed through cell cycle. CD27 /  F5 T cells
showed response kinetics, which were very similar to
those of wild-type T cells. Because the recovery of F5
TCR transgenic responder T cells was calibrated by col-
lecting a fixed number of H-Y nonresponder T cell events
during flow cytometry, CFSE profiles of wild-type and
CD27 /  F5 T cells could be overlaid (Fig. 2 B). This ap-
proach highlighted that both populations were indiscern-
ible with respect to cell cycle entry and activity. How-
ever, in all division cycles, fewer cells had accumulated in
the absence of CD27. In contrast to wild-type and
CD27 /  T cells, CD28 /  T cells had not yet entered
cell cycle at day 3 after infection. At day 4, the majority of
CD28 /  T cells had responded, but still lagged behind
wild-type T cells with respect to cell division. Enumera-
tion of F5 T cells in DLNs at days 2, 3, and 4 after infec-
tion emphasized the impact of CD27 or CD28 deletion
on the total yield of newly activated T cells (Fig. 2 C). In
the absence of either molecule, cell numbers were greatly
reduced and to a similar extent.
In conclusion, both CD27 and CD28 on activated T
cells promote expansion of virus-specific T cells in DLNs,
but do so by distinct mechanisms. Although CD28 incre-
ments cell cycle entry and activity, CD27 does not,
strongly suggesting that it enhances the accumulation of
newly activated T cells at the site of priming by improving
their survival.
Effects of CD27 Deletion on Virus-specific T Cell Division
and Accumulation in Spleen and Lung. To determine the ef-
fect of CD27 deletion on the virus-specific T cell response
in the spleen and at the site of infection, we monitored
adoptively transferred CFSE-labeled F5 T cells at later time
points (days 4–8 after primary infection). Comparison of
Figs. 2 C and 3 A shows that the wild-type F5 T cell re-
sponse in DLNs peaks at day 4 after infection. CD27 defi-
ciency compromised the F5 T cell response in terms of ki-
netics as well as cell numbers. The peak response of
CD27 /  F5 T cells was reached at day 6 and was about
twofold lower than for wild-type T cells (Fig. 3 A). In the
Figure 3. Impact of CD27 deletion on accumulation of influenza virus-
specific T cells in the spleen and lung. Adoptive transfer was performed as
outlined for Fig. 2. To standardize recovery of F5 responder T cells, 500
nonresponder H-Y T cells were collected from the lung and 1,000 from
the spleen and DLNs. (A) Kinetics of accumulation of wild-type and
CD27 /  F5 responder T cells. The absolute numbers of F5 T cells were
calculated as indicated for Fig. 2 C. Means and standard deviations are
derived from four mice per time point out of two independent experiments.
(B) Quantitative comparison of CFSE profiles of wild-type and CD27 / 
F5 T cells in the spleen and lung at day 6 after infection. Results are
representative of at least two independent experiments.T
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spleen, the wild-type T cell response peaked later than in
DLNs, at day 6 after infection (Fig. 3 A). In accordance
with the data obtained in CD27 /  mice (Fig. 1), the accu-
mulation of CD27 /  F5 T cells in the spleen was very
similar to that of wild-type F5 T cells, both in terms of ki-
netics and cell yield. In the lung, wild-type F5 T cells also
accumulated subsequent to the peak response in DLNs,
reaching maximum levels at day 6 after infection (Fig. 3 A).
Accumulation of CD27 /  F5 T cells in the lung was de-
layed as compared with wild-type and reached a maximum
that was almost threefold lower.
Overlay of CFSE profiles of wild-type and CD27 /  F5
T cells, taken from the spleen at day 6 after infection, indi-
cated that as in DLNs, CD27 deficiency had no effect on
the cell cycle profiles. It also emphasized the minor effect
of CD27 deletion on T cell accumulation in this organ
(Fig. 3 B). Overlay of CFSE profiles of wild-type and
CD27 /  F5 T cells recovered from lung at day 6 after in-
fection highlighted the reduced number of CD27-deficient
virus-specific T cells at the site of infection (Fig. 3 B).
However, because CFSE fluorescence was extinguished in
T cells that reached the lung, as has also been observed by
others (25), we could not assess a potential effect of CD27
on division of F5 T cells recovered from the lung.
We conclude that during the primary response to influ-
enza virus, CD27 on primed virus-specific T cells strongly
promotes their accumulation at the site of infection, both
in terms of kinetics and absolute numbers. In the spleen,
CD27 has only a marginal effect on virus-specific T cell ac-
cumulation and does not affect cell division.
CD27 Promotes Accumulation, but Not Division of Virus-
specific T Cells Found in the Lung. Because we wanted to
follow division cycles in virus-specific T cells recovered
from the site of infection, we used a different experimental
design. First, naive recipients were injected with F5 T cells
and subsequently infected. At day 4 after infection, T cells
were purified from DLNs and labeled with CFSE. 106
primed wild-type or CD27 /  F5 T cells were then rein-
jected together with H-Y nonresponder T cells into recipi-
ent mice, which had been infected at the same day as the
donor mice. This was done to ensure that donor T cells en-
tered in an appropriate environment. In the lung, wild-type
and CD27 /  F5 T cells were already observed 1 d after
transfer (day 5 after infection; Fig. 4 A). The next day, these
cells had not detectably divided. At day 7, a large proportion
of F5 T cells in the lung had completed multiple divisions
according to CFSE dilution. In the following days, all F5 T
cells were seen to participate in further divisions and fully
dilute the CFSE marker. CFSE profiles showed that CD27
deletion did not affect cell division in T cells recovered
from the lung (Fig. 4 A). Nevertheless, the accumulation of
F5 T cells in the lung was greatly reduced upon CD27 dele-
tion (Fig. 4 B). Peak levels were almost threefold lower for
CD27 /  compared with wild-type F5 T cells.
The finding that CD27 promotes T cell accumulation in
the lung without affecting cell division can be explained in
Figure 4. Impact of CD27 deletion on division of influ-
enza virus-specific T cells recovered from the lung. Recipient
mice were injected with naive F5 T cells and infected. At
day 4 after infection, T cells were purified from DLNs and
labeled with CFSE. Together with the H-Y T cell standard,
these were injected into recipient mice, which had been
infected with influenza virus at the same time point as
donor mice. Day 5 after infection corresponds with day 1
after transfer. Donor F5 T cells were discriminated from T
cells of the first recipient by means of the CD45.1 marker.
(A) Quantitative comparison of CFSE profiles indicating
cell divisions of wild-type and CD27 /  F5 T cells in the
lung at the indicated days after virus infection. (B) Accu-
mulation of F5 T cells in lung and DLNs of virus-infected
mice in the days after adoptive transfer. Data points are
means of two mice. Results are representative of at least
two independent experiments. (C) Quantitative comparison
of CFSE profiles indicating cell divisions of wild-type and
CD27 /  F5 T cells in DLNs at the indicated days after virus
infection.T
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several ways. First, CD27 may exert this effect solely by
promoting the generation of the primed T cell pool in
DLNs. Second, CD27 may additionally facilitate the mi-
gration of primed T cells into the lung. Third, CD27 may
additionally promote the survival of primed T cells at the
site of infection.
To examine whether CD27 facilitated further expansion
of the adoptively transferred primed T cell pool in DLNs,
we examined F5 T cell accumulation and CFSE profiles in
DLNs (Fig. 4, B and C). Primed F5 T cells were observed
in DLNs 1 d after transfer (day 5 after infection; Fig. 4 C).
The next day, the majority of F5 T cells had not yet di-
vided. At day 7, a large proportion had divided and by day 8
all cells had participated in division. The response kinetics of
DLN T cells were in fact very similar to those in the lung
(Fig. 4 A). As expected, no difference in CFSE profiles was
observed between wild-type and CD27 /  F5 T cells in
DLNs. Examination of F5 T cell accumulation in DLNs re-
vealed two striking features (Fig. 4 B). First, primed F5 T
cells were hardly affected by CD27 deletion throughout
their further expansion in DLNs. In addition, primed F5 T
cells gave rise to only up to 3   104 cells on day 7 and then
slowly declined, whereas almost 10-fold higher numbers of
wild-type F5 T cells and more than fourfold higher num-
bers of CD27 /  F5 T cells were found at the peak on day 8
in the lung. Possibly, F5 T cells divided after they had left
the site of priming. Such additional cell divisions may have
occurred in circulation and/or at the site of infection.
We conclude that CD27 does not affect cell division of
primed T cells recovered from the lung, but promotes their
accumulation at this site. This is achieved by promoting the
generation of the primed virus-specific T cell pool in
DLNs. In addition, we have evidence to suggest that CD27
supports the migration of primed T cells to the site of in-
fection and/or their survival at this site.
CD27 Promotes Activated T Cell Survival in a CD28-inde-
pendent Manner. In vivo, apoptotic T cells cannot effi-
ciently be quantified due to their efficient removal by
phagocytes. Therefore, we performed in vitro experiments
to obtain additional evidence for the hypothesis that CD27
promotes the survival of activated T cells. Upon 72 h of
stimulation in vitro via the TCR–CD3 complex, purified
wild-type T cells from naive mice had expanded signifi-
cantly as compared with medium controls (Fig. 5 A). De-
liberate costimulation with anti-CD27 or anti-CD28 mAb
similarly increased the yield of live T cells in such cultures.
Consistently, CD27 or CD28 deficiency reduced live cell
yield compared with wild-type. Costimulation of CD27 / 
cells via CD28 or vice versa revealed that these receptors
can give mutually independent signals for the expansion of
TCR-activated T cells. Analysis of nuclear fragmentation
(23) and the incidence of annexin V  cells (24) in 72-h cul-
tures showed that stimulation of the TCR–CD3 complex
induced apoptosis in a proportion of wild-type–purified T
cells (Fig. 5, B and C). The reduction in apoptosis inci-
dence that was reproducibly brought about by stimulation
of CD27 in these type of assays correlated with the in-
creased live cell yield (Fig. 5 A).
Because T cell expansion is the net result of cell division
and survival, we designed an experiment to discriminate
between these two parameters. To study effects on cell di-
vision, T cells were labeled with CFSE. To determine ef-
fects on cell viability, T cells were stained with TO-PRO-
3. This is a blue fluorescent DNA dye that only enters cells
in case the plasma membrane has become permeable. This
double labeling allowed us to determine the proportion of
nonviable T cells in each cycle of cell division by flow cy-
tometry. Fig. 6 A gives an example of the primary data de-
rived from such analysis. At 72 h after the onset of stimula-
tion with anti-CD3 mAb alone, wild-type T cells had
divided up to six times according to CFSE staining. Co-
stimulation via CD27 as well as CD28 incremented the
overall proportion of live T cells in these cultures.
Quantification of the percentage of cells in each succes-
sive cycle of cell division revealed that costimulation of
Figure 5. CD27 promotes yield of live activated T cells and counteracts
apoptosis in vitro. Purified T cells from wild-type, CD27 / , or CD28 / 
mice were stimulated for 72 h with anti-CD3 mAb in the presence or
absence of anti-CD27 or anti-CD28 mAb, as indicated. (A) Live cells
were counted using an automated cell counter. Means and standard
deviations were derived from four cultures of two separate experiments.
(B) Incidence of apoptosis as read out by nuclear fragmentation. Repre-
sentative histograms with the percentage of apoptotic events. The bar
diagram shows the mean percentages and standard deviations of apoptotic
events determined in three separate experiments. (C) Incidence of apoptosis
as read out by annexin V binding. Percentages indicate the proportion of
annexin V  cells (encircled). PIhigh cells were excluded from the analysis.
The bar diagram shows the mean percentages and standard deviations of
annexin V  cells determined in three separate experiments.T
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wild-type T cells via CD27 did not affect cell cycle entry
or progression (Fig. 6 B). In contrast, costimulation of
wild-type T cells via CD28 incremented the proportion of
cells participating in cell division, as well as the number
of division cycles they had completed in this 72-h period.
Consistently, CD27 /  T cells did not display significantly
reduced cell cycle entry or activity compared with wild-
type. CD28 could clearly stimulate cell cycle entry and
progression of CD27 /  T cells, corroborating the inde-
pendence of these costimulatory events. CD28 /  T cells
showed a dramatic reduction in cell cycle entry compared
with wild-type T cells. Costimulation via CD27 could res-
cue this to some extent, but did not bring it back to wild-
type levels.
When we plotted the absolute number of live cells
present in each division cycle, it became apparent that de-
spite its lack of effect on cell division, costimulation of
wild-type T cells via CD27 incremented the live cell yield,
from initiation of cycle throughout successive divisions
(Fig. 6 C). Plotting the ratio of nonviable/viable cell per
division was used as a means to visualize the prosurvival ef-
fects of costimulation (Fig. 6 C). Throughout successive di-
vision cycles of wild-type T cells, nonviable cells outnum-
ber viable cells. Costimulation via CD27 reverses this ratio
in favor of viable cells. A similar effect on cell survival is
seen when comparing wild-type and CD27 /  T cells.
Because CD28 promotes cell cycle activity, the effects it
exerts on the number of live cells in successive divisions
cannot be interpreted as an effect on cell survival. How-
ever, a striking survival promoting effect of CD28 was re-
vealed in these assays when we compared the survival of
TCR-stimulated wild-type and CD28 /  T cells that were
still in division round 0. CD28 /  T cells appeared to die
dramatically at the onset of stimulation, before completion
of the first cell division (Fig. 6 C). Only a very small pro-
portion of cells progressed through cell cycle. Interestingly,
costimulation via CD27 could rescue CD28 /  T cells
from death at this point: a ratio of  20:1 nonviable versus
Figure 6. CD27 does not affect
cell division but promotes survival
and yield of live activated T cells
in vitro in the presence and ab-
sence of CD28. Purified T cells
were stimulated as indicated for
Fig. 5. Cells were stained with
TO-PRO-3 dye at the end of
the culture period and the total
cell population was analyzed by
flow cytometry. (A) Dot plots
showing CFSE and TO-PRO-3
fluorescence intensities and the
overall percentage of TO-PRO-
3   (viable) and TO-PRO-3 
(nonviable) cells. Lines mark
each division round according to
CFSE dilution. Division rounds
are indicated by numbers 1–6.
(B) The percentage of total cells
(viable and nonviable) present in
each cell division round was deter-
mined  for wild-type (WT),
CD27 / , or CD28 /  T cells,
costimulated with anti-CD27 or
anti-CD28 mAb. (C) Live cell
yield was calculated per cell divi-
sion from the total number of
cells in the culture and the per-
centage viable cells in discrete CFSE  cell populations with successive diminishing fluorescence intensities (indicated by the lines in A). The ratio of
nonviable/viable cells per division was calculated from the percentages. Data points represent means of duplicate cultures. Results are representative of
four independent experiments.T
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viable cells was changed by costimulation via CD27 to a ra-
tio of 2:1 and thereby the absolute number of live cells in
division 0 was restored to wild-type levels. This finding ex-
plains the effect of CD27 on cell cycle entry seen in Fig. 6
B. Because CD27 does not promote cell division, live cell
yield in the next divisions and overall does not recover to
wild-type levels in CD28 /  T cells that are costimulated
via CD27.
In conclusion, CD27 rescues activated T cells from death
from the onset of TCR/CD3 stimulation, throughout suc-
cessive divisions. In contrast to CD28, CD27 does not af-
fect cell cycle entry or activity. CD28 also has a survival-
promoting effect, which has a dramatic impact at the onset
on TCR/CD3 stimulation before completion of the first
cell division. CD27 can compensate for the absence of
CD28 by promoting activated T cell survival at this point.
Discussion
The total number of T cells present in the antigen-spe-
cific pool at the site of priming is determined by three cell-
intrinsic parameters: the proportion of T cells entering into
the proliferating pool, their cycle activity, and their sur-
vival. In accordance with published data (2), we found that
CD28 increased cell cycle entry as well as activity. Early
studies also report that CD28 promotes the survival of acti-
vated T cells (3). From measuring [3H]thymidine incorpo-
ration at different time points after TCR stimulation, it was
concluded that this prosurvival effect came into play at a
late time point and in fact sustained the proliferative re-
sponse. However, we demonstrate that CD28 /  T cells
die in much higher frequency than wild-type T cells when
making the transition from G1 to S for the first time. CD28
strongly promotes cell survival at this point, thus greatly in-
creasing the proportion of cells taking part in further divi-
sions. The prosurvival effect of CD28 has been attributed
to up-regulation of the antiapoptotic regulator BclxL (4).
Retrovirus-mediated expression of Bcl-xL in CD28 /  T
cells indeed rescued their survival (26).
In this study, we demonstrate that unlike CD28, CD27
does not affect cell cycle entry or activity of activated T
cells. Yet, CD27 incremented the yield of live effector T
cells both in vitro and in DLNs in vivo to a similar extent
as CD28. Our data demonstrate that CD27 supports the
survival of TCR-activated T cells, from the onset of cell
division throughout successive cycles. Importantly, we find
that CD27 can stimulate survival of in vitro–activated T
cells in the absence of CD28. The dramatic cell death of
CD28 /  T cells taking place upon TCR stimulation was
almost completely rescued by deliberate CD27 stimulation
with antibody. However, inasmuch as natural CD27–
CD70 interactions took place in this in vitro system with
purified T cells alone, they did not suffice to rescue these
cells. In vivo, a different picture emerged: adoptively trans-
ferred F5 CD28 /  T cells in DLNs showed a 24-h delay
in responsiveness as compared with wild-type, but a pro-
portion of these cells did proliferate, in a very efficient
manner. In line with published results (27), we found that
in CD28 /  mice the antigen-specific CD8  T cell re-
sponse to intranasal influenza virus was reduced. However,
significant accumulation of virus-specific CD8  cells in the
lung still occurred, which was dependent on CD27.
Clearly, in a physiological context, certain virus-specific T
cells can enter into and progress through cell cycle effi-
ciently in the absence of a CD28 signal. High level of anti-
genic stimulation (TCR signals) may allow these cells to
cross the threshold for proliferation. Our study emphasizes
that such cells must be supported by CD27 for survival. In
influenza virus-infected wild-type and CD28 /   mice,
CD70 is expressed on T cells and DCs in lymphoid organs
and lung, consistent with a role for CD27–CD70 interac-
tions at these sites (12 and unpublished data).
In mice constitutively expressing the CD27 ligand CD70
in B cells, seemingly spontaneous turnover of naive T cells
into cycling effector T cells takes place in the absence of de-
liberate immunization (17, 18). Crossing of CD70 trans-
genic mice with F5 TCR transgenics has pointed out that
this turnover is driven by TCR signals, presumably induced
by environmental antigens present in the mouse facility.
Based on the data presented here, we postulate that consti-
tutive CD27–CD70 interactions taking place in CD70
transgenics improve survival of T cells induced to divide by
low level TCR signals. T cells in CD70 transgenic mice de-
velop into effector cells, which produce increased amounts
of IFN- , but not IL-2 (17). These findings emphasize that
CD27 does not stimulate IL-2 production, unlike CD28.
Whether it directs a specific effector cell differentiation pro-
gram, or is merely permissive for effector cell differentiation
to occur, is subject of investigation.
The survival-promoting activity of CD27 is in line with
the best-documented effect of TRAF-linked TNF receptor
family members, which is activation of nuclear factor  B.
Nuclear factor  B signaling has been linked to transcrip-
tional up-regulation of a variety of antiapoptotic proteins,
including the Bcl-2 family member Bfl-1 and the death re-
ceptor inhibitor c-FlipL (28, 29). At present, we do not
know the array of gene products that are controlled by
CD27 and have no complete insight into the molecular ba-
sis of its survival-promoting effect. However, in human T
cells CD27 was found to up-regulate Bcl-xL at the tran-
scriptional level (van Lier, R.A.W., personal communica-
tion). Its close homologue, OX40, was recently shown to
allow maintenance of Bcl-2 and Bcl-xL expression in the
several days after initial T cell activation. The survival de-
fect observed in OX40 /  T cells was rescued by retroviral
expression of Bcl-xL or Bcl-2 (30). Interestingly, OX40 / 
peripheral T cells were deficient in viability particularly in
the later cell divisions after TCR stimulation. CD27 sup-
ports cell survival from the onset of TCR stimulation, in
line with its expression on naive T cells. This suggests com-
plementarity with OX40, which is induced 1–2 d after T
cell activation (31).
4-1BB, another close relative of CD27, which is selec-
tively expressed on activated T cells, also supports activatedT
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
CD27 Promotes Survival of Activated T Cells 1378
T cell survival, in a CD28-independent manner (32, 33).
Similar to OX40, 4-1BB was recently found to stimulate
live cell yield in the later divisions after TCR stimulation
(32). Recently, deliberate stimulation of 4-1BB with mAb
in vivo was found to enhance the CD8  T cell response to
intranasal influenza virus infection in wild-type mice and to
rescue it to a large extent in CD28 /  mice (34). Presum-
ably, in this setting, 4-1BB has a similar effect as we found
for CD27, in that it sustained the life of activated T cells
that would normally not have survived.
The contribution of CD28 to T cell memory has not
yet been studied extensively. In a model of infection with
lymphocytic choriomeningitis virus, viral clearance during
a recall response was as effective in CD28 /  mice as in
wild-type mice (35). CD8  T cell memory was reduced
only twofold compared with wild-type, probably reflect-
ing the similarly reduced clonal burst size of the primary
response. In our model of local infection with influenza
virus, the memory response in CD28 /  animals was in
the same order of magnitude as the primary response, indi-
cating a much more profound effect of CD28 deficiency.
CD27 deletion had a similar effect on the CD8  memory
T cell response to influenza virus as CD28 deletion. It is
currently under investigation whether CD27 promotes
CD8  T cell memory in this influenza virus system by in-
creasing the number of memory T cells and/or their ca-
pacity to respond to secondary challenge. Preliminary data
indicate that the memory pool is reduced in size in the ab-
sence of CD27. Most likely, CD27 also promotes survival
of memory T cells during secondary expansion. Primary
and secondary infections were performed with the same
virus. Because CD27 deletion does not affect Ig responses
to this virus (unpublished data), the memory T cell re-
sponse in CD27    mice will not be altered via effects on
neutralizing antibody levels. In CD28     and CD27/
CD28    mice, antiviral Ig production is severely reduced.
Therefore, we have avoided quantitative comparisons be-
tween the memory T cell responses of the different re-
combinant mice.
Adoptive transfer of CFSE-labeled primed F5 T cells,
taken from DLNs at day 4 after infection, allowed us to
demonstrate that these cells continue to divide extensively.
At least a proportion of these cells still had the potential to
home to DLNs. Their relative lack of dependency on
CD27 for further accumulation in DLNs suggests that this
population represents a selection of the total pool of primed
F5 T cells recovered from DLNs of donor mice. Numbers
of primed F5 T cells in DLNs only increased from  1.5  
104 to maximally 3   104, whereas peak values of F5 T
cells found in the lung were 30   104. Possibly, a propor-
tion of adoptively transferred primed F5 T cells directly
migrated to the lung or migrated from DLNs into circula-
tion before completing cell division. Because CD27 did
not affect cell division of primed T cells recovered from the
lung, the decrease in F5 T cell accumulation in the lung
must be explained by effects on cell migration into the lung
and/or cell survival in the lung. Our accumulated evidence
strongly argues that a key function of CD27 is to prevent
death in activated T cells. Therefore, we postulate that it
promotes accumulation of effector T cells at the site of in-
fection not only by improving the survival of activated T
cells at the site of priming, but also by doing so at the site of
infection. Additional experiments are needed to test this
hypothesis. Whether this possible survival-promoting effect
of CD27 in the lung is exerted in bronchus-associated lym-
phoid tissue and/or in lung tissue remains to be established
as well.
In contrast to the virus-specific CD8  T cells in DLNs
and the lung, those in the spleen were only affected to a
minor extent by CD27 deletion. We suggest that in the
spleen, other costimulatory receptors compensate for the
absence of CD27. Possibly, expression of such receptors
and/or their ligands is more pronounced in the splenic mi-
croenvironment than in DLNs or the lung. Our data sug-
gest that the spleen, in contrast to DLNs, makes only a mi-
nor contribution to the response at the site of infection.
Alternatively, the lack of effect of CD27 deletion on acti-
vated T cells in the spleen might be masked by its profound
effect once these T cells have reached the lung.
Because the immunodominant epitopes are undefined,
the CD4  antigen-specific T cell response to influenza vi-
rus can presently not be followed in C57BL/6 mice with
MHC tetramers. However, analysis of the lung infiltrate
showed that CD27 deletion similarly decreased the size of
both CD8  and CD4  effector pools (16). CD27 is ex-
pressed on both naive subsets and collective in vitro exper-
iments unambiguously show that it impacts on both (10).
Also, in CD70 transgenic mice, CD4  and CD8  T cells
respond in a similar fashion (17, 18). Reported work on
the immune response in mice lacking 4-1BB or OX40 sig-
nals suggest that these receptors have a more selective im-
pact on either CD8  or CD4  T cells (36–38). However,
side by side comparison of mice lacking CD27, 4-1BB, or
OX40 signals in the same antigenic model system, as ongo-
ing in our laboratory, should clarify the relative impact of
these molecules and their potential complementarity.
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